Actively Recruiting
Antibiotic Dosing in Pediatric Intensive Care
Led by University Hospital, Ghent · Updated on 2026-01-16
640
Participants Needed
1
Research Sites
800 weeks
Total Duration
On this page
Sponsors
U
University Hospital, Ghent
Lead Sponsor
U
University Hospital, Antwerp
Collaborating Sponsor
AI-Summary
What this Trial Is About
Pharmacokinetics of antibiotics in critically ill neonates, infants and children
CONDITIONS
Official Title
Antibiotic Dosing in Pediatric Intensive Care
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients admitted to the pediatric intensive care unit
- Patient age/weight between 1.8 kg and 15 years
- Patient receiving antibiotic treatment (piperacillin-tazobactam, amoxicillin-clavulanate, vancomycin, teicoplanin, meropenem, ciprofloxacin, amikacin) via intermittent or continuous infusion as per institutional guidelines
- Intra-arterial or intravenous access available for blood sampling (arterial line preferred)
You will not qualify if you...
- No catheter in place for blood sampling
- Absence of parental or patient consent
- Known hypersensitivity to beta-lactam antibiotics, glycopeptides, fluoroquinolones, or aminoglycosides
- Use of extracorporeal circuits such as haemodialysis, ECMO, or peritoneal dialysis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ghent University Hospital, Hospital Pharmacy
Ghent, Belgium, 9000
Actively Recruiting
Research Team
P
Pieter De Cock, PharmD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
7
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here